IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Evonik Industries Buys Tessenderlo's Glycine Business

2:31 AM MDT | July 14, 2010 | Natasha Alperowicz

Evonik Industries says it has acquired the customer list for the pharmaceutical amino acid glycine from Tessenderlo Group (Brussels). Tessenderlo, which is currently undergoing a major portflio shuffle, announced last year that it would exit the glycine market by end of 2010 and will close the Tessenderlo based plant, because of "structural problems in the European market and competition from China." Evonik also has the option to acquire Tessenderlo's specialized glycine production equipment. Evonik makes the amino acid under strict cGMP specifications...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa